#ACCLegConf is finally here! 🎉
Welcome ACC Advocates to the nation's capital! #ACCAdvocacy is so glad you're here to advocate for your patients & profession.
View conference resources including the full agenda 🔎 https://t.co/weTqsTCDG0
Check out the latest episode of @ACCinTouch CardiaCast: PulseCheck, Dr. Andrea Russo & Dr. Erin Ferranti break down the evolving field of cardio-obstetrics and team-based care.
🎧 Listen https://t.co/FqkfFsmH0K
#CardioObstetrics#ACCRHCOB#ACCCVTeam#ACHD
Dr. Ladas (@tpladas ) wraps up a successful week using FARAPULSE, a cutting-edge device for treating AFib with electrical fields. At Lee Health, we’re proud to lead in innovative heart care.
#LeeHealthHeartInstitute
🔑 Patients should initially undergo coronary CT angiography to rule out the presence of left main disease or extensive three-vessel CAD in diabetic patients.
Read key points from a state-of-the-art review on optimizing management of stable angina: https://t.co/Ael3IOH9Qx
🔑 The spectrum of pericardial disorders encompasses pericardial inflammation, effusion, constriction, masses, and congenital anomalies.
Read more key points from an international position statement on multimodality imaging for pericardial disease: https://t.co/sTuAP6OD1M
Referral for noninvasive cardiac testing after an ED visit for chest pain made no difference in MACE at 2 years, consistent across HEART scores @JamalRanaMD@MahlerHEARTpath@bra07md@CircOutcomes https://t.co/t1T8pyqOKk
Q. Is statin use associated w/ a lower risk of mortality & MACE in patients who have #HFpEF?
A. Among Veterans w/ HFpEF & no known #ASCVD, new statin use was associated w/ reduced all-cause mortality, MACE, & hospitalization.
Read more: https://t.co/2rWOHWz7ch #JACCAdvances
Calling all champions of empowerment! I'm honored to be a speaker at the Level HER Up Conference on May 1st. Let's ignite our potential, break barriers, and empower each other to new heights. Join me for an unforgettable day of growth and support! Get your tickets today: https://t.co/sui6ZrPu1S #LevelHERUp #Empowerment #SWFL @leehealthheart
Abbott/Thoratec Corp. is recalling the Heartmate II and Heartmate 3 Left Ventricular Assist System due to long-term buildup of biological material causing an obstruction. Learn more ➡️ https://t.co/iagyOh9YYK #ACCAdvocacy#FDAUpdate
Dr. Malissa Wood, Chief Physician Executive at the Lee Health Heart Institute, is co-chairing the SWFL 2024 Go Red for Women Luncheon and invites you to join her on April 26th! ❤️
Learn more: https://t.co/KRuQqm2TDq
#SWFLGoRed#LeeHealth@AmericanHeartFL
🔑 ACC/AHA/HFSA recommends continuation of HFrEF GDMT despite improvement in LVEF & ESC does not have formal recommendations
Read key points from a review comparing clinical practice recommendations for #heartfailure in the American & European guidelines: https://t.co/pEKO3pUA3a
Lee Health Heart Institute physicians were proud to showcase the highest number of abstracts accepted to-date for the health system on topics related to cardiac care at this year’s @ACCinTouch conference!
Read more: https://t.co/aHAPvCKZZw
#ACC24#LeeHealth